How I treat idiopathic patients with inflammatory myopathies in the clinical practice

被引:24
作者
Cavagna, Lorenzo [1 ]
Monti, Sara [1 ]
Caporali, Roberto [1 ]
Gatto, Mariele [2 ]
Iaccarino, Luca [2 ]
Doria, Andrea [2 ]
机构
[1] Univ Pavia, IRCCS Policlin S Matteo Fdn, Dept Rheumatol, I-27100 Pavia, Italy
[2] Univ Padua, Dept Med, Rheumatol Unit, Padua, Italy
关键词
Idiopathic inflammatory myopathies; Antisynthetase syndrome; Therapy; Glucocorticoids; Immunosuppressants; INTERSTITIAL LUNG-DISEASE; RECALCITRANT JUVENILE DERMATOMYOSITIS; INTRAVENOUS IMMUNOGLOBULIN THERAPY; LOW-DOSE METHOTREXATE; ANTISYNTHETASE SYNDROME; MYCOPHENOLATE-MOFETIL; PULMONARY-HYPERTENSION; CALCINOSIS CUTIS; REFRACTORY ADULT; CYCLOSPORINE-A;
D O I
10.1016/j.autrev.2017.07.016
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Management of patients with idiopathic inflammatory myopathies (Ms) is challenging given the systemic nature of the disease, which is often complicated by potentially life-threatening manifestations and the lack of standardized treatment regimens. Aim of this review is to provide the currently available evidence for immunotherapy in the treatment of various manifestations of IIM in order to help clinicians in the daily management of these patients. (C) 2017 Elsevier B.V. All rights reserved.
引用
收藏
页码:999 / 1007
页数:9
相关论文
共 157 条
  • [1] Abdallah-Lotf M, 2005, EUR J DERMATOL, V15, P102
  • [2] Cutaneous improvement in refractory adult and juvenile dermatomyositis after treatment with rituximab
    Aggarwal, Rohit
    Loganathan, Priyadarshini
    Koontz, Diane
    Qi, Zengbiao
    Reed, Ann M.
    Oddis, Chester V.
    [J]. RHEUMATOLOGY, 2017, 56 (02) : 247 - 254
  • [3] Aithala R, 2017, INT J RHEUM DIS
  • [4] Efficacy of Rituximab in Refractory Inflammatory Myopathies Associated with Anti-Synthetase Auto-Antibodies: An Open-Label, Phase II Trial
    Allenbach, Yves
    Guiguet, Marguerite
    Rigolet, Aude
    Marie, Isabelle
    Hachulla, Eric
    Drouot, Laurent
    Jouen, Fabienne
    Jacquot, Serge
    Mariampillai, Kuberaka
    Musset, Lucile
    Grenier, Philippe
    Devilliers, Herve
    Hij, Adrian
    Boyer, Olivier
    Herson, Serge
    Benveniste, Olivier
    [J]. PLOS ONE, 2015, 10 (11):
  • [5] Is Lung Transplantation a Valuable Therapeutic Option for Patients With Pulmonary Polymyositis? Experiences From the Leuven Transplant Cohort
    Ameye, H.
    Ruttens, D.
    Benveniste, O.
    Verleden, G. M.
    Wuyts, W. A.
    [J]. TRANSPLANTATION PROCEEDINGS, 2014, 46 (09) : 3147 - 3153
  • [6] Long-term experience with rituximab in anti-synthetase syndrome-related interstitial lung disease
    Andersson, Helena
    Sem, Marthe
    Lund, May Brit
    Aalokken, Trond Mogens
    Gunther, Anne
    Walle-Hansen, Ragnhild
    Garen, Torhild
    Molberg, Oyvind
    [J]. RHEUMATOLOGY, 2015, 54 (08) : 1420 - 1428
  • [7] Combination antimalarials in the treatment of cutaneous dermatomyositis - A retrospective study
    Ang, GC
    Werth, VP
    [J]. ARCHIVES OF DERMATOLOGY, 2005, 141 (07) : 855 - 859
  • [8] Abatacept and Sodium Thiosulfate for Treatment of Recalcitrant Juvenile Dermatomyositis Complicated by Ulceration and Calcinosis
    Arabshahi, Bita
    Silverman, Robert A.
    Jones, Olcay Y.
    Rider, Lisa G.
    [J]. JOURNAL OF PEDIATRICS, 2012, 160 (03) : 520 - 522
  • [9] Recurrent polymyositis-associated lung disease after lung transplantation
    Arboleda, Rafael
    Gonzalez, Olga
    Cortes, Manuel
    Perez-Cerda, Francisco
    [J]. INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY, 2015, 20 (04) : 560 - 562
  • [10] Polymyositis Associated With Severe Interstitial Lung Disease Remission After Three Doses of IV Immunoglobulin
    Bakewell, Catherine J.
    Raghu, Ganesh
    [J]. CHEST, 2011, 139 (02) : 441 - 443